Role of traditional Chinese medicine monomers in cerebral ischemia/reperfusion injury:a review of the mechanism
Frontiers in Pharmacology · 16.08.2023 · 14
DOI: 10.3389/fphar.2023.1220862 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.08.2023. Verfasst von Ting Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Lanzhou University Second Hospital, Lanzhou, China. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ischemia/reperfusion (I/R) injury is a pathological process wherein reperfusion of an ischemic organ or tissue exacerbates the injury, posing a significant health threat and economic burden to patients and their families. I/R triggers a multitude of physiological and pathological events, such as inflammatory responses, oxidative stress, neuronal cell death, and disruption of the blood-brain barrier (BBB). Hence, the development of effective therapeutic strategies targeting the pathological processes resulting from I/R is crucial for the rehabilitation and long-term enhancement of the quality of life in patients with cerebral ischemia/reperfusion injury (CIRI). Traditional Chinese medicine (TCM) monomers refer to bioactive compounds extracted from Chinese herbal medicine, possessing anti-inflammatory and antioxidative effects, and the ability to modulate programmed cell death (PCD). TCM monomers have emerged as promising candidates for the treatment of CIRI and its subsequent complications. Preclinical studies have demonstrated that TCM monomers can enhance the recovery of neurological function following CIRI by mitigating oxidative stress, suppressing inflammatory responses, reducing neuronal cell death and functional impairment, as well as minimizing cerebral infarction volume. The neuroprotective effects of TCM monomers on CIRI have been extensively investigated, and a comprehensive understanding of their mechanisms can pave the way for novel approaches to I/R treatment. This review aims to update and summarize evidence of the protective effects of TCMs in CIRI, with a focus on their role in modulating oxidative stress, inflammation, PCD, glutamate excitotoxicity, Ca 2+ overload, as well as promoting blood-brain barrier repairment and angiogenesis. The main objective is to underscore the significant contribution of TCM monomers in alleviating CIRI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Lanzhou University Second Hospital, Lanzhou, China.
Zitieren
APA
Zheng, T., Jiang, T., Huang, Z., Ma, H., & Wang, M. (2023). Role of traditional Chinese medicine monomers in cerebral ischemia/reperfusion injury:a review of the mechanism. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1220862
Vancouver
Zheng T, Jiang T, Huang Z, Ma H, Wang M. Role of traditional Chinese medicine monomers in cerebral ischemia/reperfusion injury:a review of the mechanism. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1220862
BibTeX
@article{Zheng2023,
author = {Zheng, Ting and Jiang, Taotao and Huang, Zilong and Ma, Hongxiang and Wang, Manxia},
title = {Role of traditional Chinese medicine monomers in cerebral ischemia/reperfusion injury:a review of the mechanism},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1220862}
}
EUVIMED